Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-08-09
2005-08-09
Shameem, Golam M M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S203000, C548S235000, C548S252000, C548S314700, C548S341100, C514S374000, C514S399000
Reexamination Certificate
active
06927227
ABSTRACT:
aP2 inhibiting compounds are provided having the formulawherein R1, R2, R3, R4, X—Z andare as described herein.A method is also provided for treating diabetes and related diseases, especially Type II diabetes, employing such aP2 inhibitor or a combination of such aP2 inhibitor and another antidiabetic agent such as metformin, glyburide, troglitazone and/or insulin.
REFERENCES:
patent: 5348969 (1994-09-01), Romine et al.
Krasovitskii et al (1985): STN International, CAPLUS Database (Columbus, Ohio), document No. 103:71231.
Krasovitskii, B.M. et al., “Sterically Hindered Mono- and Bis(2,5-Diaryloxazoles) Containing Biphenyl Systems”, Chemistry of Heterocyclic Compounds, vol. 21, pp. 149-153 (1985) (English translation of Khimiya Geterotsiklicheskikh Soedinenii, No. 2, pp. 184-188, Feb., 1985).
Schlögl, K. et al., “Optisch aktive Tricarbonylchrom-Komplexe der Diphensäure und ihrer Derivate—Enantiomerenreinheit, Circulardichroismus und absolute Konfiguration”, Liebigs Ann. Chem., vol. 11, pp. 1877-1888 (1980).
Magnin David R.
Robl Jeffrey A.
Bristol--Myers Squibb Company
Duncan Laureles A.
Shameem Golam M M
Wang Joseph C.
LandOfFree
Heterocyclic containing biphenyl aP2 inhibitors and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic containing biphenyl aP2 inhibitors and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic containing biphenyl aP2 inhibitors and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3505846